Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Beta-taxilin (TXLNB) is a protein encoded by the human TXLNB gene and is chiefly known as a centrosomal adapter that bridges centrosome dynamics with the ubiquitin-proteasome system, particularly in cardiomyocytes (heart muscle cells)[1][2]. It plays a pivotal role in cardiac proteostasis, promoting proper disposal of damaged or misfolded proteins via the proteasome, and its deficiency leads to accumulation of ubiquitinated proteins and susceptibility to cardiac stress[1][2]. This protein also participates in intracellular vesicle trafficking and is suggested to bind syntaxins[4][5]. Its unique location and function make it a key regulator of cytoskeletal structure and protein quality control but not a direct target for therapeutic drugs at present[1][2][4].
No pharmacological mechanism of action is described for this target; drugs targeting TXLNB have not been reported
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Beta-taxilin (TXLNB).